1. Gözlü K. Sağlığın sosyal bir belirleyicisi: sağlık okuryazarlığı. SDÜ TıpFakültesi Derg. 2021;27(1):137-144. doi:10.17343/sdutfd.569301
2. Bush A. Lung development and aging. Ann Am Thorac Soc. 2016;13Suppl 5:S438-s446. doi:10.1513/AnnalsATS.201602-112AW
3. Zhou Y, Chen R. Risk factors and intervention for chronic obstructivepulmonary disease in China. Respirology. 2013;18:4-9. doi:10.1111/resp.12190
4. Almagro P, Boixeda R, Diez-Manglano J, Gómez-Antúnez M, López-García F, Recio J. Insights into chronic obstructive pulmonarydisease as critical risk factor for cardiovascular disease. Int J ChronicObstructive Pulmonary Dis. 2020;15:755-764.doi:10.2147/copd.s238214
5. Sharma G, Goodwin J. Effect of aging on respiratory system physiologyand immunology. Clin Interv Aging. 2006;1(3):253-60. doi:10.2147/ciia.2006.1.3.253
6. WHO. The top 10 causes of death. Accessed 29.01, 2023. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
7. WHO. Chronic obstructive pulmonary disease (COPD). WHO.Accessed 28.01, 2023. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
8. WHO. Top 10 causes of death in Türkiye for both sexes aged all ages.Accessed 29.01, 2023. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
9. Demir A, Büyükşirin M, Polat G, et al. KOAH çadırında ölçülen SFTsonuçları ve KOAH risk faktörlerinin değerlendirilmesi. Toraks Dergisi.2006;7(1):23-28.
10. Eisner MD, Anthonisen N, Coultas D, et al. An official AmericanThoracic Society public policy statement: Novel risk factors and theglobal burden of chronic obstructive pulmonary disease. Am J RespirCrit Care Med. 2010;182(5):693-718. doi:10.1164/rccm.200811-1757ST
11. Salvi S. Tobacco smoking and environmental risk factors for chronicobstructive pulmonary disease. Clin Chest Med. 2014;35(1):17-27.doi:10.1016/j.ccm.2013.09.011
12. Antó JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronicobstructive pulmonary disease. Eur Respir J. 2001;17(5):982-994. doi:10.1183/09031936.01.17509820
13. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLDScientific Committee. Global strategy for the diagnosis, management,and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD)Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276. doi:10.1164/ajrccm.163.5.2101039
14. GBD. Global Burden of Disease Collaborative Network. Global Burdenof Disease Study 2019 (GBD 2019) Results.Seattle, United States:Institute for Health Metrics and Evaluation (IHME), 2020. Availablefrom https://vizhub.healthdata.org/gbd-results/. Accessed 26.012023.
15. Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonarydisease: the impact of gender. Curr Opin Pulm Med. 2017;23(2):117-123.doi:10.1097/MCP.0000000000000353
16. Han MK. Chronic obstructive pulmonary disease in women: abiologically focused review with a systematic search strategy. Int JChron Obstruct Pulmon Dis. 2020;15:711-721. doi: 10.2147/COPD.S237228
17. Kirkpatrick dP, Dransfield MT. Racial and sex differences in chronicobstructive pulmonary disease susceptibility, diagnosis, and treatment.Curr Opin Pulmonary Med. 2009;15(2):100-104. doi: 10.1097/MCP.0b013e3283232825
18. Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé-Illa F. Factoresasociados a la mortalidad global en los pacientes diagnosticadosde enfermedad pulmonar obstructiva crónica. Aten Primaria.2015;47(8):498-504. doi:10.1016/j.aprim.2014.11.004
19. Seo JY, Hwang YI, Mun SY, et al. Awareness of COPD in a high riskKorean population. Yonsei Med J. 2015;56(2):362-367. doi:10.3349/ymj.2015.56.2.362
20. Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronicobstructive pulmonary disease risk and treatment outcomes. Int JChron Obstruct Pulmon Dis. 2014;9:1145-1154. doi:10.2147/COPD.S54476